Opsiscare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.59 Cr
as on 15-11-2024
- Revenue -5.82%
(FY 2023)
- Profit -44.80%
(FY 2023)
- Ebitda -5.86%
(FY 2023)
- Net Worth 666.36%
(FY 2023)
- Total Assets 35.13%
(FY 2023)
About Opsiscare Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.59 Cr.
Sirajmiyan Sindhi, Bharatkumar Patel, Digvijaysinh Jhala, and Five other members serve as directors at the Company.
- CIN/LLPIN
U74999GJ2016PTC091701
- Company No.
091701
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Opsiscare Lifesciences?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sirajmiyan Sindhi  | Director | 27-Apr-2016 | Current |
| Bharatkumar Patel | Director | 26-May-2016 | Current |
| Digvijaysinh Jhala | Director | 22-May-2023 | Current |
| Nishit Pancholi | Director | 24-Jun-2016 | Current |
| Krunalbhai Acharya | Director | 22-Apr-2017 | Current |
| Devendrasinh Vaghela | Director | 27-Apr-2016 | Current |
Financial Performance of Opsiscare Lifesciences.
Opsiscare Lifesciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.82% decrease. The company also saw a substantial fall in profitability, with a 44.8% decrease in profit. The company's net worth Soared by an impressive increase of 666.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Opsiscare Lifesciences?
Unlock access to Opsiscare Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 17 May 2024 | ₹3.10 M | Open |
Axis Bank Limited Creation Date: 04 May 2023 | ₹1.60 Cr | Open |
Others Creation Date: 03 Sep 2021 | ₹6.80 M | Open |
How Many Employees Work at Opsiscare Lifesciences?
Opsiscare Lifesciences has a workforce of 54 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Opsiscare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Opsiscare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
